Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2024

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	175 Pages	The Business Research Company	January, 2024	BRC18450601

Best Price Guarantee
Price	from $5,000
Length	175 Pages
Publisher	The Business Research Company
Published Date	January, 2024
SKU	BRC18450601

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2024

Including: 1) By Product Type: Glassia; Aralast NP; Prolastin C; Zemaira And Respreeza2) By Route Of Administration: Oral; Injection; Inhalation3) By End User: Hospitals; Specialty ClinicsCovering: Pfizer Inc.; Sanofi S.A.; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alpha-1 antitrypsin deficiency augmentation therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for alpha-1 antitrypsin deficiency augmentation therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alpha-1 antitrypsin deficiency augmentation therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Product Type: Glassia; Aralast NP; Prolastin C; Zemaira And Respreeza

2) By Route Of Administration: Oral; Injection; Inhalation

3) By End User: Hospitals; Specialty Clinics; Other End Users

Companies Mentioned: Pfizer Inc.; Sanofi S.A.; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Characteristics
3. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends And Strategies
4. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market - Macro Economic Scenario: 4.1. Impact Of High Inflation On The Market; 4.2. Ukraine-Russia War Impact On The Market; 4.3. COVID-19 Impact On The Market
5. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth: 5.1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers and Restraints; 5.1.1. Drivers Of The Market; 5.1.2. Restraints Of The Market; 5.2. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion); 5.3. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Segmentation: 6.1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Glassia; Aralast NP; Prolastin C; Zemaira And Respreeza; 6.2. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Oral; Injection; Inhalation; 6.3. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Hospitals; Specialty Clinics; Other End Users
7. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Regional And Country Analysis: 7.1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 7.2. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 8.1. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.3. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.4. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 9.1. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 9.2. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.3. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.4. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 10.1. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.2. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.3. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 11.1. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 11.2. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.3. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.4. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 12.1. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.2. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.3. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 13.1. Indonesia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.2. Indonesia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.3. Indonesia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 14.1. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 14.2. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.3. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.4. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 15.1. Western Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 15.2. Western Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.3. Western Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.4. Western Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 16.1. UK Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.2. UK Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.3. UK Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 17.1. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.2. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.3. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 18.1. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.2. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.3. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 19.1. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.2. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.3. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 20.1. Spain Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.2. Spain Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.3. Spain Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 21.1. Eastern Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 21.2. Eastern Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.3. Eastern Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.4. Eastern Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 22.1. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.2. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.3. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 23.1. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 23.2. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.3. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.4. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 24.1. USA Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 24.2. USA Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.3. USA Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.4. USA Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 25.1. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 25.2. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.3. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.4. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 26.1. South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 26.2. South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.3. South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.4. South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 27.1. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.2. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.3. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 28.1. Middle East Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 28.2. Middle East Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.3. Middle East Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.4. Middle East Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: 29.1. Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview; 29.2. Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.3. Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.4. Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Competitive Landscape And Company Profiles: 30.1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Competitive Landscape; 30.2. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Company Profiles; 30.2.1. Pfizer Inc.; 30.2.1.1. Overview; 30.2.1.2. Products and Services; 30.2.1.3. Strategy; 30.2.1.4. Financial Performance; 30.2.2. Sanofi S.A.; 30.2.2.1. Overview; 30.2.2.2. Products and Services; 30.2.2.3. Strategy; 30.2.2.4. Financial Performance; 30.2.3. AstraZeneca plc; 30.2.3.1. Overview; 30.2.3.2. Products and Services; 30.2.3.3. Strategy; 30.2.3.4. Financial Performance; 30.2.4. GlaxoSmithKline plc; 30.2.4.1. Overview; 30.2.4.2. Products and Services; 30.2.4.3. Strategy; 30.2.4.4. Financial Performance; 30.2.5. Takeda Pharmaceutical Company Limited; 30.2.5.1. Overview; 30.2.5.2. Products and Services; 30.2.5.3. Strategy; 30.2.5.4. Financial Performance
31. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Other Major And Innovative Companies: 31.1. Amgen Inc.; 31.2. Baxter International Inc.; 31.3. CSL Limited; 31.4. Biogen Inc.; 31.5. Vertex Pharmaceuticals Incorporated; 31.6. Grifols S.A.; 31.7. BioMarin Pharmaceutical Inc.; 31.8. LFB Group; 31.9. Octapharma AG; 31.10. Arrowhead Pharmaceuticals Inc.; 31.11. Kamada Ltd.; 31.12. Krystal Biotech Inc.; 31.13. Intellia Therapeutics Inc.; 31.14. Mereo BioPharma Group PLC; 31.15. Protalix BioTherapeutics Inc.
32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Competitive Benchmarking
33. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
35. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Future Outlook and Potential Analysis: 35.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market In 2028 - Countries Offering Most New Opportunities; 35.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market In 2028 - Segments Offering Most New Opportunities; 35.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market In 2028 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer